These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1308459)

  • 1. The immune destruction of red cells.
    Engelfriet CP
    Transfus Med; 1992 Mar; 2(1):1-6. PubMed ID: 1308459
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of human blood monocytes in erythrophagocytosis assay with anti-Rh antibodies.
    Brojer E; Gronkowska A; Zupańska B
    Arch Immunol Ther Exp (Warsz); 1986; 34(5-6):553-60. PubMed ID: 3496064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further hemolytic disease of the newborn caused by anti-M.
    Kanra T; Erdem G; Tekinalp G; Gürgey A; Yigit S; Dogru D
    Am J Hematol; 1996 Dec; 53(4):280-1. PubMed ID: 8948675
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro assays to predict the severity of hemolytic disease of the newborn.
    Hadley AG
    Transfus Med Rev; 1995 Oct; 9(4):302-13. PubMed ID: 8541713
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lan antigen of erythrocytes and clinical significance of anti-Lan antibody].
    Kuśnierz-Alejska G; Wiecek B
    Acta Haematol Pol; 1993; 24(2):169-75. PubMed ID: 8372617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphology of immune destruction of the erythrocytes in fetuses and newborn infants].
    Gurevich PS
    Arkh Patol; 1977; 39(6):19-24. PubMed ID: 907504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rh hemolytic disease of the newborn--the disease eradicated by immunology.
    Zipursky A
    Clin Obstet Gynecol; 1977 Sep; 20(3):759-72. PubMed ID: 408069
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of the fetal immune system in the pathogenesis of RhD-hemolytic disease of newborns.
    Gurevich P; Erina S; Gershon S; Zusman I
    Hum Antibodies; 1997; 8(2):76-89. PubMed ID: 9289392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic disease of the newborn caused by anti-Jkb.
    Merlob P; Litwin A; Reisner SH; Cohen IJ; Zaizov R
    Pediatr Hematol Oncol; 1987; 4(4):357-60. PubMed ID: 3152944
    [No Abstract]   [Full Text] [Related]  

  • 10. The James Blundell Award Lecture 2007: do we really understand immune red cell destruction?
    Garratty G
    Transfus Med; 2008 Dec; 18(6):321-34. PubMed ID: 19140815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of irregular red cell antibodies and their significance in blood transfusion and antenatal care.
    Spielmann W; Seidl S
    Vox Sang; 1974; 26(6):551-9. PubMed ID: 4212267
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioassays to determine the clinical significance of red cell alloantibodies based on Fc receptor-induced destruction of red cells sensitized by IgG.
    Engelfriet CP; Overbeeke MA; Dooren MC; Ouwehand WH; von dem Borne AE
    Transfusion; 1994 Jul; 34(7):617-26. PubMed ID: 8053042
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn.
    Hadley AG
    Vox Sang; 1998; 74 Suppl 2():375-83. PubMed ID: 9704470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced immune phagocytosis of monocytes from neonates whose mothers produce HLA antibodies.
    Neppert J; Mueller-Eckhardt G; Heine O
    Vox Sang; 1988; 54(3):177-80. PubMed ID: 3369140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Destruction of IgG anti-A sensitized erythrocytes by mononuclear leucocytes from normal and ABO haemolytic disease affected infants.
    Romano EL; Rossi Devivo ML; Soyano A; Linares J
    Clin Exp Immunol; 1984 Feb; 55(2):451-8. PubMed ID: 6538121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.
    Dooren MC; van Kamp IL; Kanhai HH; Gravenhorst JB; von dem Borne AE; Engelfriet CP
    Vox Sang; 1993; 65(1):55-8. PubMed ID: 8362515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild course of fetal RhD haemolytic disease due to maternal alloimmunisation to paternal HLA class I and II antigens.
    Eichler H; Zieger W; Neppert J; Kerowgan M; Melchert F; Goldmann SF
    Vox Sang; 1995; 68(4):243-7. PubMed ID: 7660645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemolytic disease of the newborn probably due to anti-ELO, an antibody to a low frequency red cell antigen.
    Ford DS; Stern DA; Hawksworth DN; Lubenko A; Pope JM; Chana HS; Better PJ
    Vox Sang; 1992; 62(3):169-72. PubMed ID: 1609518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of complement in immunohematology.
    Garratty G
    Crit Rev Clin Lab Sci; 1984; 20(1):25-56. PubMed ID: 6373144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.